Delivery Order SPE2DR25D1002-SPE2DR26FGH9F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,893.61 to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 30-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,730.75 on September 25, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 units) under a firm fixed-price contract valued at $3,320.62. This non-set-aside delivery order, with an ultimate completion date of May 7, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Cyclosporine 0.05% Eye Emulsion (30 units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by August 7, 2025, reflecting the expedited nature of pharmaceutical supply fulfillment to support federal...
- The Defense Logistics Agency awarded a $21,750.49 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-unit package). This firm fixed-price, competitively awarded contract requires delivery by September 10, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the open competition process through which it was procured. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units, with a ceiling value of $1,091.41. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,625.76 to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units. This is a firm fixed-price, non-set-aside contract with performance to be completed by July 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $20,448.66 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $2,777.72 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) under a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and was...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGH9FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 30-unit quantities, with a ceiling value of $6,777.94 and completion target of October 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and a major distribution hub for federal pharmaceutical procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant portfolio of federal contracts covering diverse therapeutic domains including specialty medications, vaccines, and medical devices for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current award represents a routine fulfillment of pharmaceutical supply needs under this expansive vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 10/23/25 |